Skip to main content
Clinical Trials/ITMCTR2000003858
ITMCTR2000003858
Not yet recruiting
Phase 1

A clinical study on improvement of asthma control level in patients with refractory asthma by Ba-Duan-Jin lung rehabilitation exercise

Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\.People who asthma cannot be well controlled for at least 6 months after standardized treatment with two or more controlled drugs including medium and high dose ICS and long\-acting beta2\-receptor agonist (LABA). The criterion to achieve good Control is Asthma Control Test (ACT) score less than 20\.
  • 2\.Non acute exacerbation.
  • 3\.Aged from 18\~65 years.

Exclusion Criteria

  • 1\. Wheezing caused by tuberculosis, fungus, tumor, irritant gas allergy or other respiratory diseases that may cause wheezing or dyspnea.
  • 3\. Pregnant or lactating women, allergic to research drugs.
  • 4\. Complicated with cardiovascular, liver, kidney and hematopoietic system and other serious primary diseases, psychiatric patients.
  • 5\. Concurrent with severe cardiac insufficiency.
  • 6\. Combined with motor nervous system disease can not complete badanjin exercise.
  • 7\. Containing factors affecting the observation of curative effect.
  • 8\. Those who do not meet the inclusion criteria, do not use the medicine according to the regulations, cannot judge the curative effect or the incomplete data will affect the judgement of curative effect or safety.

Outcomes

Primary Outcomes

Not specified

Similar Trials